292 related articles for article (PubMed ID: 22564513)
21. Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver.
Dombrowski F; Stieger B; Beuers U
Lab Invest; 2006 Feb; 86(2):166-74. PubMed ID: 16344857
[TBL] [Abstract][Full Text] [Related]
22. The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump.
Gooijert KE; Havinga R; Wolters H; Wang R; Ling V; Tazuma S; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G450-7. PubMed ID: 25552583
[TBL] [Abstract][Full Text] [Related]
23. Protective Functions of ZO-2/Tjp2 Expressed in Hepatocytes and Cholangiocytes Against Liver Injury and Cholestasis.
Xu J; Kausalya PJ; Van Hul N; Caldez MJ; Xu S; Ong AGM; Woo WL; Mohamed Ali S; Kaldis P; Hunziker W
Gastroenterology; 2021 May; 160(6):2103-2118. PubMed ID: 33465371
[TBL] [Abstract][Full Text] [Related]
24. Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment.
Cheng Y; Freeden C; Zhang Y; Abraham P; Shen H; Wescott D; Humphreys WG; Gan J; Lai Y
Biopharm Drug Dispos; 2016 Jul; 37(5):276-86. PubMed ID: 27059119
[TBL] [Abstract][Full Text] [Related]
25. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.
Ananthanarayanan M; Balasubramanian N; Makishima M; Mangelsdorf DJ; Suchy FJ
J Biol Chem; 2001 Aug; 276(31):28857-65. PubMed ID: 11387316
[TBL] [Abstract][Full Text] [Related]
26. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
[TBL] [Abstract][Full Text] [Related]
27. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
[TBL] [Abstract][Full Text] [Related]
28. Vesicle- and Hepatocyte-Based Assays for Identification of Drug Candidates Inhibiting BSEP Function.
Van Brantegem P; Deferm N; Qi B; De Vocht T; Annaert P
Methods Mol Biol; 2019; 1981():55-73. PubMed ID: 31016647
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
[TBL] [Abstract][Full Text] [Related]
30. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
Gonzales E; Grosse B; Schuller B; Davit-Spraul A; Conti F; Guettier C; Cassio D; Jacquemin E
Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872
[TBL] [Abstract][Full Text] [Related]
31. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
[TBL] [Abstract][Full Text] [Related]
32. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
Gonzales E; Grosse B; Cassio D; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
[TBL] [Abstract][Full Text] [Related]
34. Function and Expression of Bile Salt Export Pump in Suspension Human Hepatocytes.
Chothe PP; Pemberton R; Hariparsad N
Drug Metab Dispos; 2021 Apr; 49(4):314-321. PubMed ID: 33472814
[TBL] [Abstract][Full Text] [Related]
35. The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease.
Lam P; Soroka CJ; Boyer JL
Semin Liver Dis; 2010 May; 30(2):125-33. PubMed ID: 20422495
[TBL] [Abstract][Full Text] [Related]
36. Effect of Ursodeoxycholic Acid on the Expression of the Hepatocellular Bile Acid Transporters (Ntcp and bsep) in Rats With Estrogen-Induced Cholestasis.
Micheline D; Emmanuel J; Serge E
J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):185-91. PubMed ID: 12187295
[TBL] [Abstract][Full Text] [Related]
37. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.
Chen Y; Song X; Valanejad L; Vasilenko A; More V; Qiu X; Chen W; Lai Y; Slitt A; Stoner M; Yan B; Deng R
Hepatology; 2013 Apr; 57(4):1530-41. PubMed ID: 23213087
[TBL] [Abstract][Full Text] [Related]
38. Regulatory mechanisms of the bile salt export pump (BSEP/ABCB11) and its role in related diseases.
Ren T; Pang L; Dai W; Wu S; Kong J
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101641. PubMed ID: 33581308
[TBL] [Abstract][Full Text] [Related]
39. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
[TBL] [Abstract][Full Text] [Related]
40. Functional expression of the canalicular bile salt export pump of human liver.
Noé J; Stieger B; Meier PJ
Gastroenterology; 2002 Nov; 123(5):1659-66. PubMed ID: 12404240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
